QSAR - Meeting in Philadelphia on Drug Discovery Applications of Cheminformatics & Modeling

----- Forwarded by Accelrys Administrator/Accelrys on 07/15/2005 02:20 PM
-----

Barry Hardy <barry.hardy||tiscalinet.ch>
07/15/2005 04:29 AM

To
osman:_:accelrys.com, "Alexander Tropsha" <alex_tropsha{:}unc.edu>
cc

Subject
Meeting in Philadelphia on Drug Discovery Applications of Cheminformatics
& Modeling

Dear Osman, Alex:

I am not sure if one can post directly to the QSAR list any more so I
would be grateful if you could post these 2 announcements - one below and
one following on the equivalent European meeting.

Thanks!
Barry

eCheminfo US Autumn 2005 InterAction Meeting

The eCheminfo US Autumn 2005 meeting will be taking place at Bryn Mawr
College, Philadelphia, US, 11-12 October. Program information and
registration is available through the eCheminfo website at
http://echeminfo.com/

The theme of the meeting is the application of cheminformatics and
chemical modelling to drug discovery and will include the following
sessions:

Virtual Screening, Docking & Scoring, chaired by Max Cummings (Johnson &
Johnson); Web-based Services in Drug Design, chaired by Marc Nicklaus,
(National Institutes of Health); Protein Folding, Misfolding &
Aggregation: Applications to Disease, chaired by Nikolay V. Dokholyan
(University of North Carolina); New Developments in Biophysical
Applications of Quantum Mechanics, chaired by Ken Merz/Lance Westerhoff
(QuantumBio); Simulation of Membranes & Ion Channels, co-chaired by
Richard Pastor (FDA) & Michael Klein (University of Pennsylvania)

Invited Speakers include:
Emanuele Perola (Vertex), Mark McGann (Openeye), John Irwin (UCSF), Renee
DesJarlais (Johnson & Johnson), Willem Nissink (Cambridge Crystallographic
Data Centre), Brad Feuston (Merck), Brett Tounge (Johnson & Johnson),
Steve Bryant (NCBI), David Covell (NCI), Andrew Miranker (Yale
University), David Teplow (David Geffen School of Medicine at UCLA), Ron
Wetzel (University of Tenessee Medical Center), Michael Thorpe (Arizona
State University), Feng Ding (University of North Carolina), Mike Pitman
(IBM), Jeff Klauda (NIH), Emad Tajkhorshid (Beckman Institute, University
of Illinois at Urbana-Champaign), Richard Pastor (FDA), Preston Moore
(USIP), Martin Peters (Penn State), Darrin York (University of Minnesota)

The eCheminfo meetings will have exhibitor tables for software demos and
evening poster sessions; posters will also be available for viewing
through the website. Posters can be on any informatics or modeling topic
of relevance to drug discovery. Those who cannot make the meetings are
also able to register to access all presentations with audio and posters
through the eCheminfo website.

Poster Abstracts (ca. 300 words) should be sent to eCheminfo at
douglasconnect.com

Papers submitted with either seminar or poster presentations will be
refereed for consideration for publication in the Molecular Simulation
journal.

The InnovationWell US community of practice Autumn meeting will be taking
place at the same location and on the same dates as the eCheminfo US
meeting. This meeting will be covering semantic web applications in drug
discovery, personalised medicine, knowledge management and transfer in
R&D, clinical trial productivity, drug safety knowledge management and
predictive toxicology. All eCheminfo registrants will also have access to
the InnovationWell meeting activities. (See http://innovationwell.net/ for
more details).

What is the eCheminfo Community of Practice?
http://echeminfo.com/

eCheminfo is a global Community of Practice (CoP) dedicated to the sharing
of research and development of best practices in cheminformatics and
chemical modelling of relevance to drug discovery. The CoP involves a
diversity of subject matter expertise including experienced professionals
from the life science and pharmaceutical industry, vendors, research
institutes, universities and government.

eCheminfo is committed to the core value of outreach with diverse groups
in the commercial, government and academic sectors for the sharing of best
practices and the development of strategies, resources and methodologies
that address specific issues in improved drug discovery and productivity.
Communications activities deploy virtual approaches and a collaboration
environment, in addition to regional discussion- and networking-designed
face-to-face InterAction meetings. Membership includes access to over 100
seminars from top industry and academic experts, discussion conference
calls, and networking facilities.

Barry Hardy, PhD
Community of Practice Manager
Douglas Connect, Switzerland
+41 61 851 0170 (office)
www.douglasconnect.com

Click here to report this email as spam.
Received on 2005-07-15 - 18:24 GMT